Is Galmed Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: GLMD) stock is to Strong Buy GLMD stock.
Out of 1 analyst, 1 (100%) are recommending GLMD as a Strong Buy, 0 (0%) are recommending GLMD as a Buy, 0 (0%) are recommending GLMD as a Hold, 0 (0%) are recommending GLMD as a Sell, and 0 (0%) are recommending GLMD as a Strong Sell.
What is GLMD's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: GLMD) forecast ROE is N/A, which is considered weak.
What is GLMD's Price Target?
According to 1 Wall Street analyst that have issued a 1 year GLMD price target, the average GLMD price target is $4.00, with the highest GLMD stock price forecast at $4.00 and the lowest GLMD stock price forecast at $4.00.
The Wall Street analyst predicted that Galmed Pharmaceuticals's share price could reach $4.00 by Jul 24, 2024. The average Galmed Pharmaceuticals stock price prediction forecasts a potential upside of 586.11% from the current GLMD share price of $0.58.
What is GLMD's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: GLMD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.11%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.